1. Home
  2. IINN vs UBX Comparison

IINN vs UBX Comparison

Compare IINN & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IINN
  • UBX
  • Stock Information
  • Founded
  • IINN 2018
  • UBX 2009
  • Country
  • IINN Israel
  • UBX United States
  • Employees
  • IINN N/A
  • UBX N/A
  • Industry
  • IINN Medical/Dental Instruments
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IINN Health Care
  • UBX Health Care
  • Exchange
  • IINN Nasdaq
  • UBX Nasdaq
  • Market Cap
  • IINN 15.9M
  • UBX 16.2M
  • IPO Year
  • IINN 2021
  • UBX 2018
  • Fundamental
  • Price
  • IINN $0.61
  • UBX $1.00
  • Analyst Decision
  • IINN
  • UBX Strong Buy
  • Analyst Count
  • IINN 0
  • UBX 3
  • Target Price
  • IINN N/A
  • UBX $5.33
  • AVG Volume (30 Days)
  • IINN 397.2K
  • UBX 139.9K
  • Earning Date
  • IINN 05-06-2025
  • UBX 04-22-2025
  • Dividend Yield
  • IINN N/A
  • UBX N/A
  • EPS Growth
  • IINN N/A
  • UBX N/A
  • EPS
  • IINN N/A
  • UBX N/A
  • Revenue
  • IINN N/A
  • UBX N/A
  • Revenue This Year
  • IINN N/A
  • UBX N/A
  • Revenue Next Year
  • IINN N/A
  • UBX N/A
  • P/E Ratio
  • IINN N/A
  • UBX N/A
  • Revenue Growth
  • IINN N/A
  • UBX N/A
  • 52 Week Low
  • IINN $0.54
  • UBX $0.85
  • 52 Week High
  • IINN $2.45
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • IINN 42.48
  • UBX 42.00
  • Support Level
  • IINN $0.53
  • UBX $0.93
  • Resistance Level
  • IINN $0.67
  • UBX $1.03
  • Average True Range (ATR)
  • IINN 0.07
  • UBX 0.08
  • MACD
  • IINN 0.01
  • UBX 0.04
  • Stochastic Oscillator
  • IINN 48.76
  • UBX 81.57

About IINN Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: